F16.15

Clinical Causes: Repeated or high-dose use of hallucinogenic drugs such as LSD, psilocybin (magic mushrooms), or mescaline. Prolonged abuse leading to psychological dependence. Individual predisposition due to genetic or mental health history that increases vulnerability to psychosis. Concurrent use of other substances, such as alcohol or stimulants, which may exacerbate mental health effects. Environmental factors and stressors that may trigger or worsen psychotic episodes.

Key Symptoms: Hallucinations that can be visual, auditory, or tactile. Delusional thinking, involving false beliefs that are resistant to reason. Disorganized thinking and speech. agitation, restlessness, or paranoia. Altered perception of reality, time, or self-awareness. Emotional disturbances such as anxiety, fear, or euphoria. Possible physical symptoms like increased heart rate, sweating, or dilated pupils during episodes.

Diagnosis Path: Diagnosing this condition involves a comprehensive psychiatric evaluation, including a detailed medical and substance use history. Clinicians observe signs and symptoms consistent with psychosis associated with hallucinogen use. Laboratory tests may be used to rule out other causes of psychosis, and diagnostic criteria outlined in the DSM-5 are often applied to confirm the diagnosis. The key is establishing a link between hallucinogen ingestion and the onset of psychotic symptoms.

Treatment Protocols: Treatment approaches focus on managing symptoms, preventing relapse, and supporting mental health recovery. Strategies include: - **Detoxification and cessation of hallucinogen use**: Supportive care during withdrawal and abstinence. - **Psychiatric medications**: Antipsychotics may be prescribed to manage hallucinations, delusions, and agitation. - **Psychotherapy**: Cognitive-behavioral therapy (CBT) can help individuals understand and cope with their condition. - **Supportive counseling and social support**: To assist in rehabilitation and reintegration into daily life. - **Monitoring and managing co-occurring mental health disorders**: Recognizing and treating any additional psychiatric issues. Long-term treatment may involve ongoing therapy and support to prevent relapses and address underlying mental health vulnerabilities.